Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy

Journal of Clinical Oncology

Volumn 24, Issue 22, 2006, Pages 3583-3589

  Razzouk, Bassem I ^a   Hord, Jeffrey D ^a   Hockenberry, Marilyn ^a   Hinds, Pamela S ^a   Feusner, James ^a   Williams, Denise ^a   Rackoff, Wayne R ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; ANTIANEMIC AGENT;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FEMALE; FEVER; HUMAN; HYPERTENSION; INFECTION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; THORAX PAIN; THROMBOSIS; BONE MARROW; DRUG EFFECT; ERYTHROCYTE TRANSFUSION; HEALTH STATUS; IRON DEFICIENCY ANEMIA; NEOPLASM; PRESCHOOL CHILD;

ADOLESCENT; ANEMIA, HYPOCHROMIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; EPOETIN ALFA; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH STATUS; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; NEOPLASMS; QUALITY OF LIFE;

EID: 33747031725     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.4371     Document Type: Article

References (18)

1. Cella D, Kallich J, McDermott A, et al: The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: Results from five randomized clinical trials. Ann Oncol 15: 979-986, 2004
2. Bennetts G, Bertolone S, Bray G, et al: Erythropoietin reduces volumes of red cell transfusions required in some subsets of children with acute lymphocytic leukemia. Blood 86:853a, 1995 (suppl 1; abstr 3401)
3. Porter JC, Leahey A, Polise K, et al: Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: A randomized, double-blind, placebo-controlled trial. J Pediatr 129:656-660, 1996
4. Kronberger M, Fischmeister G, Poetschger U, et al: Reduction in transfusion requirements with early epoetin alfa treatment in pediatric patients with solid tumors: A case-control study. Pediatr Hematol Oncol 19:95-105, 2002
5. Bolonaki I, Stiakaki E, Lydaki E, et al: Treatment with recombinant human erythropoietin in children with malignancies. Pediatr Hematol Oncol 13:111-121, 1996
6. Varan A, Buyukpamukcu M, Kutluk T, et al: Recombinant human erythropoietin treatment for chemotherapy-related anemia in children. Pediatrics 103:E16, 1999
7. Csaki C, Ferencz T, Schuler D, et al: Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours. Eur J Cancer 34:364-367, 1998
8. Buyukpamukcu M, Varan A, Kutluk T, et al: Is epoetin alfa a treatment option for chemotherapy-related anemia in children? Med Pediatr Oncol 39: 455-458, 2002
9. Yilmaz D, Cetingul N, Kantar M, et al: A single institutional experience: Is epoetin alpha effective in anemic children with cancer? Pediatr Hematol Oncol 21:1-8, 2004
10. Beck MN, Beck D: Recombinant erythropoietin in acute chemotherapy-induced anemia of children with cancer. Med Pediatr Oncol 25:17-21, 1995
11. Henze G, Michon J, Morland B, et al: Phase III randomized study: Efficacy of epoetin alfa in reducing blood transfusions in newly diagnosed pediatric cancer patients receiving chemotherapy. Proc Am Soc Clin Oncol 21:387a, 2002 (abstr 1547)
12. Varni JW, Seid M, Kurtin PS: PedsQL 4.0: Reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39:800-812, 2001
13. Varni JW, Burwinkle TM, Katz ER, et al: The PedsQL in pediatric cancer: Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 94:2090-2106, 2002
14. Varni JW, Seid M, Rode CA: The PedsQL: Measurement model for the pediatric quality of life inventory. Med Care 37:126-139, 1999
15. Cohen J: Statistical Power Analysis for the Behavioral Sciences. New York, NY, Academic Press, 1988
16. Anderson TW: An Introduction to Multivariate Statistical Analysis (ed 3). Hoboken, NJ, Wiley, 2003
17. Witzig TE, Silberstein PT, Loprinzi CL, et al: Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol 23:2606-2617, 2005
18. Auerbach M, Ballard H, Trout JR, et al: Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial. J Clin Oncol 22:1301-1307, 2004